PPARA and metabolic dysfunction-associated steatohepatitis: These observations were in alignment with our findings that testosterone and estradiol treatment normalized NASH pathological features, restored PPARα and PPARδ expression, and reduced PPARγ protein levels comparing to the ORX + HFHF group.